nodes	percent_of_prediction	percent_of_DWPC	metapath
Desmopressin—PTGS2—skin cancer	0.687	1	CbGaD
Desmopressin—AVPR2—Arf6 trafficking events—EXOC2—skin cancer	0.0062	0.0819	CbGpPWpGaD
Desmopressin—AVPR1B—Peptide GPCRs—MC1R—skin cancer	0.00385	0.0509	CbGpPWpGaD
Desmopressin—AVPR1A—Peptide GPCRs—MC1R—skin cancer	0.00267	0.0353	CbGpPWpGaD
Desmopressin—AVPR2—Peptide GPCRs—MC1R—skin cancer	0.00265	0.035	CbGpPWpGaD
Desmopressin—PTGS2—leg—skin cancer	0.00222	0.117	CbGeAlD
Desmopressin—PTGS2—hindlimb—skin cancer	0.00198	0.104	CbGeAlD
Desmopressin—AVPR1B—Peptide ligand-binding receptors—MC1R—skin cancer	0.00181	0.0239	CbGpPWpGaD
Desmopressin—AVPR2—G alpha (s) signalling events—MC1R—skin cancer	0.00175	0.0232	CbGpPWpGaD
Desmopressin—PTGS2—appendage—skin cancer	0.0017	0.0895	CbGeAlD
Desmopressin—AVPR2—head—skin cancer	0.00164	0.0863	CbGeAlD
Desmopressin—AVPR1B—GPCRs, Class A Rhodopsin-like—MC1R—skin cancer	0.00142	0.0187	CbGpPWpGaD
Desmopressin—PTGS2—skin epidermis—skin cancer	0.00141	0.0744	CbGeAlD
Desmopressin—AVPR1B—GPCR ligand binding—PTCH2—skin cancer	0.00128	0.0169	CbGpPWpGaD
Desmopressin—AVPR1A—Peptide ligand-binding receptors—MC1R—skin cancer	0.00126	0.0166	CbGpPWpGaD
Desmopressin—AVPR2—Peptide ligand-binding receptors—MC1R—skin cancer	0.00125	0.0165	CbGpPWpGaD
Desmopressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.00121	0.016	CbGpPWpGaD
Desmopressin—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—skin cancer	0.00121	0.016	CbGpPWpGaD
Desmopressin—AVPR2—G alpha (s) signalling events—PTGER4—skin cancer	0.00115	0.0152	CbGpPWpGaD
Desmopressin—PTGS1—endothelium—skin cancer	0.00107	0.0565	CbGeAlD
Desmopressin—PTGS2—Signaling mediated by p38-alpha and p38-beta—MITF—skin cancer	0.00103	0.0136	CbGpPWpGaD
Desmopressin—PTGS2—endothelium—skin cancer	0.00103	0.054	CbGeAlD
Desmopressin—PTGS1—blood vessel—skin cancer	0.000989	0.0521	CbGeAlD
Desmopressin—AVPR1A—GPCRs, Class A Rhodopsin-like—MC1R—skin cancer	0.000983	0.013	CbGpPWpGaD
Desmopressin—AVPR2—GPCRs, Class A Rhodopsin-like—MC1R—skin cancer	0.000976	0.0129	CbGpPWpGaD
Desmopressin—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—skin cancer	0.000964	0.0127	CbGpPWpGaD
Desmopressin—PTGS2—blood vessel—skin cancer	0.000945	0.0498	CbGeAlD
Desmopressin—AVPR1B—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	0.000932	0.0123	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR ligand binding—MC1R—skin cancer	0.000925	0.0122	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR ligand binding—PTCH2—skin cancer	0.000887	0.0117	CbGpPWpGaD
Desmopressin—AVPR2—GPCR ligand binding—PTCH2—skin cancer	0.00088	0.0116	CbGpPWpGaD
Desmopressin—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—skin cancer	0.000843	0.0111	CbGpPWpGaD
Desmopressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.000842	0.0111	CbGpPWpGaD
Desmopressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—MC1R—skin cancer	0.000836	0.011	CbGpPWpGaD
Desmopressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.000799	0.0106	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—RHOU—skin cancer	0.000794	0.0105	CbGpPWpGaD
Desmopressin—PTGS1—nipple—skin cancer	0.000715	0.0377	CbGeAlD
Desmopressin—PTGS1—Overview of nanoparticle effects—PTGS2—skin cancer	0.000661	0.00873	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR ligand binding—SHH—skin cancer	0.000659	0.00871	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—PTCH2—skin cancer	0.000657	0.00867	CbGpPWpGaD
Desmopressin—AVPR1A—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	0.000646	0.00854	CbGpPWpGaD
Desmopressin—AVPR2—GPCRs, Class A Rhodopsin-like—PTGER4—skin cancer	0.000642	0.00848	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR ligand binding—MC1R—skin cancer	0.000641	0.00847	CbGpPWpGaD
Desmopressin—AVPR2—GPCR ligand binding—MC1R—skin cancer	0.000637	0.00841	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR ligand binding—PTCH1—skin cancer	0.000625	0.00826	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR ligand binding—SMO—skin cancer	0.000625	0.00826	CbGpPWpGaD
Desmopressin—AVPR1B—GPCR ligand binding—PTGER4—skin cancer	0.000608	0.00804	CbGpPWpGaD
Desmopressin—AVPR2—Transmembrane transport of small molecules—SLC12A2—skin cancer	0.000607	0.00803	CbGpPWpGaD
Desmopressin—Chills—Bleomycin—skin cancer	0.000561	0.00257	CcSEcCtD
Desmopressin—Dyspnoea—Imiquimod—skin cancer	0.000557	0.00255	CcSEcCtD
Desmopressin—Somnolence—Imiquimod—skin cancer	0.000556	0.00254	CcSEcCtD
Desmopressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.000554	0.00731	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—RHOU—skin cancer	0.000551	0.00727	CbGpPWpGaD
Desmopressin—Dyspepsia—Imiquimod—skin cancer	0.00055	0.00252	CcSEcCtD
Desmopressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—PTGER4—skin cancer	0.00055	0.00726	CbGpPWpGaD
Desmopressin—PTGS1—Eicosanoid Synthesis—PTGS2—skin cancer	0.000548	0.00724	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—RHOU—skin cancer	0.000547	0.00722	CbGpPWpGaD
Desmopressin—Erythema—Bleomycin—skin cancer	0.000544	0.00249	CcSEcCtD
Desmopressin—Decreased appetite—Imiquimod—skin cancer	0.000543	0.00249	CcSEcCtD
Desmopressin—Flushing—Dactinomycin—skin cancer	0.000541	0.00248	CcSEcCtD
Desmopressin—Hypersensitivity—Vemurafenib—skin cancer	0.00054	0.00247	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Imiquimod—skin cancer	0.00054	0.00247	CcSEcCtD
Desmopressin—Fatigue—Imiquimod—skin cancer	0.000539	0.00247	CcSEcCtD
Desmopressin—Pain—Imiquimod—skin cancer	0.000535	0.00245	CcSEcCtD
Desmopressin—Conjunctivitis—Fluorouracil—skin cancer	0.000526	0.00241	CcSEcCtD
Desmopressin—Asthenia—Vemurafenib—skin cancer	0.000526	0.00241	CcSEcCtD
Desmopressin—Hallucination—Temozolomide—skin cancer	0.000525	0.0024	CcSEcCtD
Desmopressin—Chills—Dactinomycin—skin cancer	0.000523	0.00239	CcSEcCtD
Desmopressin—AVPR1B—GPCR downstream signaling—MC1R—skin cancer	0.000523	0.00691	CbGpPWpGaD
Desmopressin—Urinary tract disorder—Temozolomide—skin cancer	0.000521	0.00238	CcSEcCtD
Desmopressin—Oedema peripheral—Temozolomide—skin cancer	0.000519	0.00238	CcSEcCtD
Desmopressin—Pruritus—Vemurafenib—skin cancer	0.000519	0.00237	CcSEcCtD
Desmopressin—Connective tissue disorder—Temozolomide—skin cancer	0.000518	0.00237	CcSEcCtD
Desmopressin—Urethral disorder—Temozolomide—skin cancer	0.000517	0.00237	CcSEcCtD
Desmopressin—Feeling abnormal—Imiquimod—skin cancer	0.000515	0.00236	CcSEcCtD
Desmopressin—PTGS2—Spinal Cord Injury—CSPG4—skin cancer	0.000514	0.00679	CbGpPWpGaD
Desmopressin—Gastrointestinal pain—Imiquimod—skin cancer	0.000511	0.00234	CcSEcCtD
Desmopressin—Epistaxis—Fluorouracil—skin cancer	0.00051	0.00234	CcSEcCtD
Desmopressin—Hyponatraemia—Docetaxel—skin cancer	0.000509	0.00233	CcSEcCtD
Desmopressin—Visual impairment—Temozolomide—skin cancer	0.000508	0.00233	CcSEcCtD
Desmopressin—Erythema—Dactinomycin—skin cancer	0.000507	0.00232	CcSEcCtD
Desmopressin—PTGS1—connective tissue—skin cancer	0.000507	0.0267	CbGeAlD
Desmopressin—Ill-defined disorder—Bleomycin—skin cancer	0.000505	0.00231	CcSEcCtD
Desmopressin—Diarrhoea—Vemurafenib—skin cancer	0.000501	0.00229	CcSEcCtD
Desmopressin—Urticaria—Imiquimod—skin cancer	0.000497	0.00227	CcSEcCtD
Desmopressin—Abdominal pain—Imiquimod—skin cancer	0.000494	0.00226	CcSEcCtD
Desmopressin—Body temperature increased—Imiquimod—skin cancer	0.000494	0.00226	CcSEcCtD
Desmopressin—Eye disorder—Temozolomide—skin cancer	0.000493	0.00225	CcSEcCtD
Desmopressin—Malaise—Bleomycin—skin cancer	0.000491	0.00225	CcSEcCtD
Desmopressin—Flushing—Temozolomide—skin cancer	0.000489	0.00224	CcSEcCtD
Desmopressin—Cardiac disorder—Temozolomide—skin cancer	0.000489	0.00224	CcSEcCtD
Desmopressin—Rhinitis—Fluorouracil—skin cancer	0.000487	0.00223	CcSEcCtD
Desmopressin—PTGS2—connective tissue—skin cancer	0.000485	0.0255	CbGeAlD
Desmopressin—Dizziness—Vemurafenib—skin cancer	0.000485	0.00222	CcSEcCtD
Desmopressin—PTGS1—epithelium—skin cancer	0.000481	0.0254	CbGeAlD
Desmopressin—Angiopathy—Temozolomide—skin cancer	0.000478	0.00219	CcSEcCtD
Desmopressin—Immune system disorder—Temozolomide—skin cancer	0.000476	0.00218	CcSEcCtD
Desmopressin—Mediastinal disorder—Temozolomide—skin cancer	0.000475	0.00217	CcSEcCtD
Desmopressin—Cough—Bleomycin—skin cancer	0.000475	0.00217	CcSEcCtD
Desmopressin—AVPR1B—Signaling by GPCR—MC1R—skin cancer	0.000475	0.00627	CbGpPWpGaD
Desmopressin—Chills—Temozolomide—skin cancer	0.000473	0.00216	CcSEcCtD
Desmopressin—Dehydration—Docetaxel—skin cancer	0.000471	0.00216	CcSEcCtD
Desmopressin—Ill-defined disorder—Dactinomycin—skin cancer	0.000471	0.00215	CcSEcCtD
Desmopressin—Vomiting—Vemurafenib—skin cancer	0.000466	0.00213	CcSEcCtD
Desmopressin—Myalgia—Bleomycin—skin cancer	0.000463	0.00212	CcSEcCtD
Desmopressin—Chest pain—Bleomycin—skin cancer	0.000463	0.00212	CcSEcCtD
Desmopressin—Orthostatic hypotension—Docetaxel—skin cancer	0.000463	0.00212	CcSEcCtD
Desmopressin—Rash—Vemurafenib—skin cancer	0.000462	0.00211	CcSEcCtD
Desmopressin—Mental disorder—Temozolomide—skin cancer	0.000462	0.00211	CcSEcCtD
Desmopressin—Dermatitis—Vemurafenib—skin cancer	0.000462	0.00211	CcSEcCtD
Desmopressin—Hypersensitivity—Imiquimod—skin cancer	0.000461	0.00211	CcSEcCtD
Desmopressin—PTGS2—epithelium—skin cancer	0.00046	0.0242	CbGeAlD
Desmopressin—Headache—Vemurafenib—skin cancer	0.000459	0.0021	CcSEcCtD
Desmopressin—Erythema—Temozolomide—skin cancer	0.000459	0.0021	CcSEcCtD
Desmopressin—Malnutrition—Temozolomide—skin cancer	0.000459	0.0021	CcSEcCtD
Desmopressin—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—skin cancer	0.000458	0.00606	CbGpPWpGaD
Desmopressin—PTGS1—skin of body—skin cancer	0.000458	0.0241	CbGeAlD
Desmopressin—Discomfort—Bleomycin—skin cancer	0.000458	0.00209	CcSEcCtD
Desmopressin—Malaise—Dactinomycin—skin cancer	0.000458	0.00209	CcSEcCtD
Desmopressin—AVPR1A—GPCR ligand binding—SHH—skin cancer	0.000457	0.00604	CbGpPWpGaD
Desmopressin—Cramp muscle—Docetaxel—skin cancer	0.000456	0.00209	CcSEcCtD
Desmopressin—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000456	0.00209	CcSEcCtD
Desmopressin—AVPR1A—Signaling by GPCR—PTCH2—skin cancer	0.000455	0.00601	CbGpPWpGaD
Desmopressin—AVPR2—GPCR ligand binding—SHH—skin cancer	0.000454	0.00599	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—PTCH2—skin cancer	0.000452	0.00597	CbGpPWpGaD
Desmopressin—Asthenia—Imiquimod—skin cancer	0.000448	0.00205	CcSEcCtD
Desmopressin—Confusional state—Bleomycin—skin cancer	0.000448	0.00205	CcSEcCtD
Desmopressin—Oedema—Bleomycin—skin cancer	0.000444	0.00203	CcSEcCtD
Desmopressin—Anaphylactic shock—Bleomycin—skin cancer	0.000444	0.00203	CcSEcCtD
Desmopressin—Pruritus—Imiquimod—skin cancer	0.000442	0.00202	CcSEcCtD
Desmopressin—Infection—Bleomycin—skin cancer	0.000441	0.00202	CcSEcCtD
Desmopressin—PTGS2—skin of body—skin cancer	0.000438	0.0231	CbGeAlD
Desmopressin—Nausea—Vemurafenib—skin cancer	0.000435	0.00199	CcSEcCtD
Desmopressin—AVPR1A—GPCR ligand binding—PTCH1—skin cancer	0.000433	0.00572	CbGpPWpGaD
Desmopressin—AVPR1A—GPCR ligand binding—SMO—skin cancer	0.000433	0.00572	CbGpPWpGaD
Desmopressin—Myalgia—Dactinomycin—skin cancer	0.000432	0.00198	CcSEcCtD
Desmopressin—AVPR2—GPCR ligand binding—SMO—skin cancer	0.00043	0.00568	CbGpPWpGaD
Desmopressin—AVPR2—GPCR ligand binding—PTCH1—skin cancer	0.00043	0.00568	CbGpPWpGaD
Desmopressin—Diarrhoea—Imiquimod—skin cancer	0.000428	0.00196	CcSEcCtD
Desmopressin—Discomfort—Dactinomycin—skin cancer	0.000427	0.00195	CcSEcCtD
Desmopressin—Ill-defined disorder—Temozolomide—skin cancer	0.000426	0.00195	CcSEcCtD
Desmopressin—Anorexia—Bleomycin—skin cancer	0.000423	0.00194	CcSEcCtD
Desmopressin—Erythema—Fluorouracil—skin cancer	0.000423	0.00194	CcSEcCtD
Desmopressin—Agitation—Temozolomide—skin cancer	0.000422	0.00193	CcSEcCtD
Desmopressin—AVPR1A—GPCR ligand binding—PTGER4—skin cancer	0.000422	0.00557	CbGpPWpGaD
Desmopressin—AVPR2—GPCR ligand binding—PTGER4—skin cancer	0.000419	0.00553	CbGpPWpGaD
Desmopressin—PTGS1—mammalian vulva—skin cancer	0.000418	0.022	CbGeAlD
Desmopressin—Oedema—Dactinomycin—skin cancer	0.000414	0.0019	CcSEcCtD
Desmopressin—Malaise—Temozolomide—skin cancer	0.000414	0.00189	CcSEcCtD
Desmopressin—Dizziness—Imiquimod—skin cancer	0.000413	0.00189	CcSEcCtD
Desmopressin—Vertigo—Temozolomide—skin cancer	0.000412	0.00189	CcSEcCtD
Desmopressin—Infection—Dactinomycin—skin cancer	0.000411	0.00188	CcSEcCtD
Desmopressin—Palpitations—Temozolomide—skin cancer	0.000406	0.00186	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000405	0.00185	CcSEcCtD
Desmopressin—Cough—Temozolomide—skin cancer	0.000401	0.00183	CcSEcCtD
Desmopressin—Paraesthesia—Bleomycin—skin cancer	0.000399	0.00182	CcSEcCtD
Desmopressin—Weight increased—Docetaxel—skin cancer	0.000399	0.00182	CcSEcCtD
Desmopressin—Convulsion—Temozolomide—skin cancer	0.000398	0.00182	CcSEcCtD
Desmopressin—Vomiting—Imiquimod—skin cancer	0.000397	0.00182	CcSEcCtD
Desmopressin—Hypertension—Temozolomide—skin cancer	0.000396	0.00181	CcSEcCtD
Desmopressin—Dyspnoea—Bleomycin—skin cancer	0.000396	0.00181	CcSEcCtD
Desmopressin—Anorexia—Dactinomycin—skin cancer	0.000395	0.00181	CcSEcCtD
Desmopressin—Rash—Imiquimod—skin cancer	0.000394	0.0018	CcSEcCtD
Desmopressin—Dermatitis—Imiquimod—skin cancer	0.000394	0.0018	CcSEcCtD
Desmopressin—Headache—Imiquimod—skin cancer	0.000392	0.00179	CcSEcCtD
Desmopressin—Myalgia—Temozolomide—skin cancer	0.000391	0.00179	CcSEcCtD
Desmopressin—Anxiety—Temozolomide—skin cancer	0.000389	0.00178	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000388	0.00178	CcSEcCtD
Desmopressin—AVPR1B—Signaling Pathways—PTCH2—skin cancer	0.000388	0.00512	CbGpPWpGaD
Desmopressin—Discomfort—Temozolomide—skin cancer	0.000386	0.00177	CcSEcCtD
Desmopressin—Decreased appetite—Bleomycin—skin cancer	0.000386	0.00177	CcSEcCtD
Desmopressin—Pain—Bleomycin—skin cancer	0.00038	0.00174	CcSEcCtD
Desmopressin—Conjunctivitis—Docetaxel—skin cancer	0.00038	0.00174	CcSEcCtD
Desmopressin—Confusional state—Temozolomide—skin cancer	0.000378	0.00173	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000377	0.00173	CcSEcCtD
Desmopressin—Anaphylactic shock—Temozolomide—skin cancer	0.000375	0.00171	CcSEcCtD
Desmopressin—Oedema—Temozolomide—skin cancer	0.000375	0.00171	CcSEcCtD
Desmopressin—Infection—Temozolomide—skin cancer	0.000372	0.0017	CcSEcCtD
Desmopressin—Nausea—Imiquimod—skin cancer	0.000371	0.0017	CcSEcCtD
Desmopressin—Epistaxis—Docetaxel—skin cancer	0.000368	0.00169	CcSEcCtD
Desmopressin—Nervous system disorder—Temozolomide—skin cancer	0.000367	0.00168	CcSEcCtD
Desmopressin—Convulsion—Fluorouracil—skin cancer	0.000366	0.00168	CcSEcCtD
Desmopressin—Feeling abnormal—Bleomycin—skin cancer	0.000366	0.00167	CcSEcCtD
Desmopressin—Skin disorder—Temozolomide—skin cancer	0.000364	0.00166	CcSEcCtD
Desmopressin—AVPR1A—GPCR downstream signaling—MC1R—skin cancer	0.000362	0.00479	CbGpPWpGaD
Desmopressin—Hyperhidrosis—Temozolomide—skin cancer	0.000362	0.00166	CcSEcCtD
Desmopressin—Chest pain—Fluorouracil—skin cancer	0.00036	0.00165	CcSEcCtD
Desmopressin—Myalgia—Fluorouracil—skin cancer	0.00036	0.00165	CcSEcCtD
Desmopressin—Decreased appetite—Dactinomycin—skin cancer	0.00036	0.00165	CcSEcCtD
Desmopressin—PTGS1—Overview of nanoparticle effects—IL6—skin cancer	0.00036	0.00475	CbGpPWpGaD
Desmopressin—AVPR2—GPCR downstream signaling—MC1R—skin cancer	0.00036	0.00475	CbGpPWpGaD
Desmopressin—PTGS1—female reproductive system—skin cancer	0.000358	0.0188	CbGeAlD
Desmopressin—Fatigue—Dactinomycin—skin cancer	0.000357	0.00163	CcSEcCtD
Desmopressin—Anorexia—Temozolomide—skin cancer	0.000357	0.00163	CcSEcCtD
Desmopressin—Discomfort—Fluorouracil—skin cancer	0.000356	0.00163	CcSEcCtD
Desmopressin—PTGS2—lymphoid tissue—skin cancer	0.000354	0.0187	CbGeAlD
Desmopressin—Pain—Dactinomycin—skin cancer	0.000354	0.00162	CcSEcCtD
Desmopressin—Urticaria—Bleomycin—skin cancer	0.000353	0.00161	CcSEcCtD
Desmopressin—Rhinitis—Docetaxel—skin cancer	0.000352	0.00161	CcSEcCtD
Desmopressin—Body temperature increased—Bleomycin—skin cancer	0.000351	0.00161	CcSEcCtD
Desmopressin—Confusional state—Fluorouracil—skin cancer	0.000348	0.00159	CcSEcCtD
Desmopressin—Urinary tract disorder—Docetaxel—skin cancer	0.000346	0.00158	CcSEcCtD
Desmopressin—Oedema peripheral—Docetaxel—skin cancer	0.000345	0.00158	CcSEcCtD
Desmopressin—Anaphylactic shock—Fluorouracil—skin cancer	0.000345	0.00158	CcSEcCtD
Desmopressin—Oedema—Fluorouracil—skin cancer	0.000345	0.00158	CcSEcCtD
Desmopressin—Connective tissue disorder—Docetaxel—skin cancer	0.000345	0.00158	CcSEcCtD
Desmopressin—AVPR1B—GPCR downstream signaling—PTGER4—skin cancer	0.000344	0.00454	CbGpPWpGaD
Desmopressin—Urethral disorder—Docetaxel—skin cancer	0.000344	0.00157	CcSEcCtD
Desmopressin—Infection—Fluorouracil—skin cancer	0.000343	0.00157	CcSEcCtD
Desmopressin—PTGS2—female reproductive system—skin cancer	0.000342	0.018	CbGeAlD
Desmopressin—Feeling abnormal—Dactinomycin—skin cancer	0.000341	0.00156	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000341	0.00156	CcSEcCtD
Desmopressin—Insomnia—Temozolomide—skin cancer	0.000339	0.00155	CcSEcCtD
Desmopressin—Gastrointestinal pain—Dactinomycin—skin cancer	0.000339	0.00155	CcSEcCtD
Desmopressin—Nervous system disorder—Fluorouracil—skin cancer	0.000338	0.00155	CcSEcCtD
Desmopressin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CDK4—skin cancer	0.000338	0.00447	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—SHH—skin cancer	0.000338	0.00447	CbGpPWpGaD
Desmopressin—Visual impairment—Docetaxel—skin cancer	0.000338	0.00155	CcSEcCtD
Desmopressin—Tachycardia—Fluorouracil—skin cancer	0.000337	0.00154	CcSEcCtD
Desmopressin—Paraesthesia—Temozolomide—skin cancer	0.000336	0.00154	CcSEcCtD
Desmopressin—Dyspnoea—Temozolomide—skin cancer	0.000334	0.00153	CcSEcCtD
Desmopressin—Somnolence—Temozolomide—skin cancer	0.000333	0.00152	CcSEcCtD
Desmopressin—Dyspepsia—Temozolomide—skin cancer	0.00033	0.00151	CcSEcCtD
Desmopressin—AVPR1A—Signaling by GPCR—MC1R—skin cancer	0.000329	0.00435	CbGpPWpGaD
Desmopressin—Anorexia—Fluorouracil—skin cancer	0.000329	0.00151	CcSEcCtD
Desmopressin—Eye disorder—Docetaxel—skin cancer	0.000328	0.0015	CcSEcCtD
Desmopressin—Abdominal pain—Dactinomycin—skin cancer	0.000327	0.0015	CcSEcCtD
Desmopressin—Body temperature increased—Dactinomycin—skin cancer	0.000327	0.0015	CcSEcCtD
Desmopressin—Hypersensitivity—Bleomycin—skin cancer	0.000327	0.0015	CcSEcCtD
Desmopressin—AVPR2—Signaling by GPCR—MC1R—skin cancer	0.000327	0.00432	CbGpPWpGaD
Desmopressin—Decreased appetite—Temozolomide—skin cancer	0.000326	0.00149	CcSEcCtD
Desmopressin—Flushing—Docetaxel—skin cancer	0.000325	0.00149	CcSEcCtD
Desmopressin—Cardiac disorder—Docetaxel—skin cancer	0.000325	0.00149	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Temozolomide—skin cancer	0.000323	0.00148	CcSEcCtD
Desmopressin—Fatigue—Temozolomide—skin cancer	0.000323	0.00148	CcSEcCtD
Desmopressin—AVPR1B—Signaling by GPCR—SMO—skin cancer	0.000321	0.00424	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—PTCH1—skin cancer	0.000321	0.00424	CbGpPWpGaD
Desmopressin—Pain—Temozolomide—skin cancer	0.00032	0.00147	CcSEcCtD
Desmopressin—Constipation—Temozolomide—skin cancer	0.00032	0.00147	CcSEcCtD
Desmopressin—Asthenia—Bleomycin—skin cancer	0.000319	0.00146	CcSEcCtD
Desmopressin—Angiopathy—Docetaxel—skin cancer	0.000318	0.00146	CcSEcCtD
Desmopressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	0.000317	0.00418	CbGpPWpGaD
Desmopressin—Immune system disorder—Docetaxel—skin cancer	0.000317	0.00145	CcSEcCtD
Desmopressin—Mediastinal disorder—Docetaxel—skin cancer	0.000316	0.00145	CcSEcCtD
Desmopressin—Chills—Docetaxel—skin cancer	0.000315	0.00144	CcSEcCtD
Desmopressin—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000314	0.00144	CcSEcCtD
Desmopressin—Pruritus—Bleomycin—skin cancer	0.000314	0.00144	CcSEcCtD
Desmopressin—Insomnia—Fluorouracil—skin cancer	0.000312	0.00143	CcSEcCtD
Desmopressin—AVPR1B—Signaling by GPCR—PTGER4—skin cancer	0.000312	0.00412	CbGpPWpGaD
Desmopressin—Paraesthesia—Fluorouracil—skin cancer	0.00031	0.00142	CcSEcCtD
Desmopressin—Feeling abnormal—Temozolomide—skin cancer	0.000309	0.00141	CcSEcCtD
Desmopressin—Dyspnoea—Fluorouracil—skin cancer	0.000308	0.00141	CcSEcCtD
Desmopressin—Mental disorder—Docetaxel—skin cancer	0.000307	0.00141	CcSEcCtD
Desmopressin—Somnolence—Fluorouracil—skin cancer	0.000307	0.0014	CcSEcCtD
Desmopressin—Gastrointestinal pain—Temozolomide—skin cancer	0.000306	0.0014	CcSEcCtD
Desmopressin—Malnutrition—Docetaxel—skin cancer	0.000305	0.0014	CcSEcCtD
Desmopressin—Erythema—Docetaxel—skin cancer	0.000305	0.0014	CcSEcCtD
Desmopressin—Hypersensitivity—Dactinomycin—skin cancer	0.000305	0.0014	CcSEcCtD
Desmopressin—PTGS1—Arachidonic acid metabolism—PTGS2—skin cancer	0.000305	0.00402	CbGpPWpGaD
Desmopressin—Dyspepsia—Fluorouracil—skin cancer	0.000304	0.00139	CcSEcCtD
Desmopressin—Decreased appetite—Fluorouracil—skin cancer	0.0003	0.00137	CcSEcCtD
Desmopressin—PTGS1—head—skin cancer	0.000299	0.0157	CbGeAlD
Desmopressin—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000298	0.00136	CcSEcCtD
Desmopressin—Urticaria—Temozolomide—skin cancer	0.000298	0.00136	CcSEcCtD
Desmopressin—Asthenia—Dactinomycin—skin cancer	0.000297	0.00136	CcSEcCtD
Desmopressin—Abdominal pain—Temozolomide—skin cancer	0.000296	0.00136	CcSEcCtD
Desmopressin—Body temperature increased—Temozolomide—skin cancer	0.000296	0.00136	CcSEcCtD
Desmopressin—Pain—Fluorouracil—skin cancer	0.000295	0.00135	CcSEcCtD
Desmopressin—AVPR1B—Signaling Pathways—GLI2—skin cancer	0.000294	0.00388	CbGpPWpGaD
Desmopressin—Muscle spasms—Docetaxel—skin cancer	0.000293	0.00134	CcSEcCtD
Desmopressin—PTGS2—Overview of nanoparticle effects—IL6—skin cancer	0.000286	0.00377	CbGpPWpGaD
Desmopressin—PTGS2—head—skin cancer	0.000286	0.015	CbGeAlD
Desmopressin—Feeling abnormal—Fluorouracil—skin cancer	0.000284	0.0013	CcSEcCtD
Desmopressin—Diarrhoea—Dactinomycin—skin cancer	0.000283	0.0013	CcSEcCtD
Desmopressin—Vomiting—Bleomycin—skin cancer	0.000282	0.00129	CcSEcCtD
Desmopressin—AVPR1B—Signaling Pathways—MC1R—skin cancer	0.00028	0.0037	CbGpPWpGaD
Desmopressin—Rash—Bleomycin—skin cancer	0.00028	0.00128	CcSEcCtD
Desmopressin—Dermatitis—Bleomycin—skin cancer	0.00028	0.00128	CcSEcCtD
Desmopressin—AVPR1B—Signaling Pathways—GLI1—skin cancer	0.000276	0.00365	CbGpPWpGaD
Desmopressin—Hypersensitivity—Temozolomide—skin cancer	0.000276	0.00126	CcSEcCtD
Desmopressin—Urticaria—Fluorouracil—skin cancer	0.000274	0.00125	CcSEcCtD
Desmopressin—Syncope—Docetaxel—skin cancer	0.000274	0.00125	CcSEcCtD
Desmopressin—Body temperature increased—Fluorouracil—skin cancer	0.000273	0.00125	CcSEcCtD
Desmopressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	0.000273	0.0036	CbGpPWpGaD
Desmopressin—Palpitations—Docetaxel—skin cancer	0.00027	0.00123	CcSEcCtD
Desmopressin—AVPR1A—Signaling Pathways—PTCH2—skin cancer	0.000269	0.00355	CbGpPWpGaD
Desmopressin—Asthenia—Temozolomide—skin cancer	0.000269	0.00123	CcSEcCtD
Desmopressin—Loss of consciousness—Docetaxel—skin cancer	0.000268	0.00123	CcSEcCtD
Desmopressin—AVPR2—Signaling Pathways—PTCH2—skin cancer	0.000267	0.00353	CbGpPWpGaD
Desmopressin—Cough—Docetaxel—skin cancer	0.000266	0.00122	CcSEcCtD
Desmopressin—Pruritus—Temozolomide—skin cancer	0.000265	0.00121	CcSEcCtD
Desmopressin—Convulsion—Docetaxel—skin cancer	0.000264	0.00121	CcSEcCtD
Desmopressin—Nausea—Bleomycin—skin cancer	0.000264	0.00121	CcSEcCtD
Desmopressin—Hypertension—Docetaxel—skin cancer	0.000264	0.00121	CcSEcCtD
Desmopressin—Vomiting—Dactinomycin—skin cancer	0.000263	0.0012	CcSEcCtD
Desmopressin—AVPR1B—Signaling Pathways—SUFU—skin cancer	0.000262	0.00346	CbGpPWpGaD
Desmopressin—Rash—Dactinomycin—skin cancer	0.000261	0.00119	CcSEcCtD
Desmopressin—Chest pain—Docetaxel—skin cancer	0.00026	0.00119	CcSEcCtD
Desmopressin—Myalgia—Docetaxel—skin cancer	0.00026	0.00119	CcSEcCtD
Desmopressin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000258	0.00118	CcSEcCtD
Desmopressin—Diarrhoea—Temozolomide—skin cancer	0.000256	0.00117	CcSEcCtD
Desmopressin—Hypersensitivity—Fluorouracil—skin cancer	0.000254	0.00116	CcSEcCtD
Desmopressin—Confusional state—Docetaxel—skin cancer	0.000251	0.00115	CcSEcCtD
Desmopressin—Anaphylactic shock—Docetaxel—skin cancer	0.000249	0.00114	CcSEcCtD
Desmopressin—Oedema—Docetaxel—skin cancer	0.000249	0.00114	CcSEcCtD
Desmopressin—Dizziness—Temozolomide—skin cancer	0.000248	0.00113	CcSEcCtD
Desmopressin—Infection—Docetaxel—skin cancer	0.000247	0.00113	CcSEcCtD
Desmopressin—Nausea—Dactinomycin—skin cancer	0.000246	0.00113	CcSEcCtD
Desmopressin—Shock—Docetaxel—skin cancer	0.000245	0.00112	CcSEcCtD
Desmopressin—Nervous system disorder—Docetaxel—skin cancer	0.000244	0.00112	CcSEcCtD
Desmopressin—Pruritus—Fluorouracil—skin cancer	0.000244	0.00112	CcSEcCtD
Desmopressin—Tachycardia—Docetaxel—skin cancer	0.000243	0.00111	CcSEcCtD
Desmopressin—Skin disorder—Docetaxel—skin cancer	0.000242	0.00111	CcSEcCtD
Desmopressin—AVPR1A—GPCR downstream signaling—PTGER4—skin cancer	0.000238	0.00315	CbGpPWpGaD
Desmopressin—Vomiting—Temozolomide—skin cancer	0.000238	0.00109	CcSEcCtD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	0.000238	0.00314	CbGpPWpGaD
Desmopressin—Anorexia—Docetaxel—skin cancer	0.000237	0.00109	CcSEcCtD
Desmopressin—AVPR2—GPCR downstream signaling—PTGER4—skin cancer	0.000237	0.00313	CbGpPWpGaD
Desmopressin—Rash—Temozolomide—skin cancer	0.000236	0.00108	CcSEcCtD
Desmopressin—Diarrhoea—Fluorouracil—skin cancer	0.000236	0.00108	CcSEcCtD
Desmopressin—Dermatitis—Temozolomide—skin cancer	0.000236	0.00108	CcSEcCtD
Desmopressin—Headache—Temozolomide—skin cancer	0.000235	0.00107	CcSEcCtD
Desmopressin—AVPR1A—Signaling by GPCR—SHH—skin cancer	0.000234	0.0031	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—SHH—skin cancer	0.000233	0.00308	CbGpPWpGaD
Desmopressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.000232	0.00306	CbGpPWpGaD
Desmopressin—Dizziness—Fluorouracil—skin cancer	0.000228	0.00104	CcSEcCtD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.000228	0.00301	CbGpPWpGaD
Desmopressin—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000227	0.00104	CcSEcCtD
Desmopressin—Insomnia—Docetaxel—skin cancer	0.000225	0.00103	CcSEcCtD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	0.000225	0.00298	CbGpPWpGaD
Desmopressin—Paraesthesia—Docetaxel—skin cancer	0.000224	0.00102	CcSEcCtD
Desmopressin—Nausea—Temozolomide—skin cancer	0.000222	0.00102	CcSEcCtD
Desmopressin—AVPR1A—Signaling by GPCR—SMO—skin cancer	0.000222	0.00294	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—PTCH1—skin cancer	0.000222	0.00294	CbGpPWpGaD
Desmopressin—Dyspnoea—Docetaxel—skin cancer	0.000222	0.00102	CcSEcCtD
Desmopressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.000222	0.00293	CbGpPWpGaD
Desmopressin—Somnolence—Docetaxel—skin cancer	0.000221	0.00101	CcSEcCtD
Desmopressin—AVPR2—Signaling by GPCR—SMO—skin cancer	0.000221	0.00292	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—PTCH1—skin cancer	0.000221	0.00292	CbGpPWpGaD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	0.00022	0.0029	CbGpPWpGaD
Desmopressin—Vomiting—Fluorouracil—skin cancer	0.000219	0.001	CcSEcCtD
Desmopressin—Dyspepsia—Docetaxel—skin cancer	0.000219	0.001	CcSEcCtD
Desmopressin—Rash—Fluorouracil—skin cancer	0.000218	0.000996	CcSEcCtD
Desmopressin—Dermatitis—Fluorouracil—skin cancer	0.000217	0.000995	CcSEcCtD
Desmopressin—Decreased appetite—Docetaxel—skin cancer	0.000217	0.000991	CcSEcCtD
Desmopressin—AVPR1A—Signaling by GPCR—PTGER4—skin cancer	0.000216	0.00286	CbGpPWpGaD
Desmopressin—Headache—Fluorouracil—skin cancer	0.000216	0.000989	CcSEcCtD
Desmopressin—Gastrointestinal disorder—Docetaxel—skin cancer	0.000215	0.000984	CcSEcCtD
Desmopressin—AVPR2—Signaling by GPCR—PTGER4—skin cancer	0.000215	0.00284	CbGpPWpGaD
Desmopressin—Fatigue—Docetaxel—skin cancer	0.000215	0.000983	CcSEcCtD
Desmopressin—Pain—Docetaxel—skin cancer	0.000213	0.000975	CcSEcCtD
Desmopressin—Constipation—Docetaxel—skin cancer	0.000213	0.000975	CcSEcCtD
Desmopressin—PTGS1—lymph node—skin cancer	0.000209	0.011	CbGeAlD
Desmopressin—Feeling abnormal—Docetaxel—skin cancer	0.000205	0.000939	CcSEcCtD
Desmopressin—Nausea—Fluorouracil—skin cancer	0.000205	0.000938	CcSEcCtD
Desmopressin—AVPR1A—Signaling Pathways—GLI2—skin cancer	0.000204	0.00269	CbGpPWpGaD
Desmopressin—Gastrointestinal pain—Docetaxel—skin cancer	0.000204	0.000932	CcSEcCtD
Desmopressin—AVPR2—Signaling Pathways—GLI2—skin cancer	0.000202	0.00267	CbGpPWpGaD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	0.000201	0.00266	CbGpPWpGaD
Desmopressin—PTGS2—lymph node—skin cancer	0.0002	0.0105	CbGeAlD
Desmopressin—AVPR1B—Signaling Pathways—SHH—skin cancer	0.0002	0.00264	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—RASA1—skin cancer	0.000199	0.00262	CbGpPWpGaD
Desmopressin—Body temperature increased—Docetaxel—skin cancer	0.000197	0.000901	CcSEcCtD
Desmopressin—Abdominal pain—Docetaxel—skin cancer	0.000197	0.000901	CcSEcCtD
Desmopressin—AVPR1A—Signaling Pathways—MC1R—skin cancer	0.000194	0.00257	CbGpPWpGaD
Desmopressin—PTGS1—Selenium Micronutrient Network—PTGS2—skin cancer	0.000194	0.00256	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—MC1R—skin cancer	0.000193	0.00255	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—GLI1—skin cancer	0.000192	0.00253	CbGpPWpGaD
Desmopressin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—skin cancer	0.000191	0.00253	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—GLI1—skin cancer	0.00019	0.00251	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—PTCH1—skin cancer	0.000189	0.0025	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—SMO—skin cancer	0.000189	0.0025	CbGpPWpGaD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	0.000189	0.0025	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—PTGER4—skin cancer	0.000184	0.00244	CbGpPWpGaD
Desmopressin—Hypersensitivity—Docetaxel—skin cancer	0.000184	0.00084	CcSEcCtD
Desmopressin—AVPR1A—Signaling Pathways—SUFU—skin cancer	0.000182	0.0024	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	0.000181	0.00239	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—SUFU—skin cancer	0.00018	0.00238	CbGpPWpGaD
Desmopressin—Asthenia—Docetaxel—skin cancer	0.000179	0.000818	CcSEcCtD
Desmopressin—Pruritus—Docetaxel—skin cancer	0.000176	0.000806	CcSEcCtD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	0.000173	0.00229	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—CDKN2A—skin cancer	0.000171	0.00226	CbGpPWpGaD
Desmopressin—Diarrhoea—Docetaxel—skin cancer	0.00017	0.00078	CcSEcCtD
Desmopressin—PTGS2—Spinal Cord Injury—CDK4—skin cancer	0.00017	0.00225	CbGpPWpGaD
Desmopressin—Dizziness—Docetaxel—skin cancer	0.000165	0.000754	CcSEcCtD
Desmopressin—AVPR1B—Signaling Pathways—FOXO4—skin cancer	0.000163	0.00215	CbGpPWpGaD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	0.000161	0.00212	CbGpPWpGaD
Desmopressin—Vomiting—Docetaxel—skin cancer	0.000158	0.000725	CcSEcCtD
Desmopressin—Rash—Docetaxel—skin cancer	0.000157	0.000719	CcSEcCtD
Desmopressin—Dermatitis—Docetaxel—skin cancer	0.000157	0.000718	CcSEcCtD
Desmopressin—Headache—Docetaxel—skin cancer	0.000156	0.000714	CcSEcCtD
Desmopressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	0.000154	0.00203	CbGpPWpGaD
Desmopressin—Nausea—Docetaxel—skin cancer	0.000148	0.000677	CcSEcCtD
Desmopressin—PTGS2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	0.000147	0.00194	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—SHH—skin cancer	0.000138	0.00183	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—RASA1—skin cancer	0.000138	0.00182	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—SHH—skin cancer	0.000138	0.00182	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—RASA1—skin cancer	0.000137	0.00181	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—SMO—skin cancer	0.000131	0.00173	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—PTCH1—skin cancer	0.000131	0.00173	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—SMO—skin cancer	0.00013	0.00172	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PTCH1—skin cancer	0.00013	0.00172	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—PTGER4—skin cancer	0.000128	0.00169	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—PTGER4—skin cancer	0.000127	0.00168	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—NRAS—skin cancer	0.000124	0.00164	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	0.000116	0.00153	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—FOXO4—skin cancer	0.000113	0.00149	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—FOXO4—skin cancer	0.000112	0.00148	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—TERT—skin cancer	0.000109	0.00144	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—KRAS—skin cancer	0.000107	0.00141	CbGpPWpGaD
Desmopressin—PTGS1—Selenium Micronutrient Network—IL6—skin cancer	0.000106	0.00139	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PLIN2—skin cancer	0.000102	0.00134	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—NRAS—skin cancer	9.17e-05	0.00121	CbGpPWpGaD
Desmopressin—PTGS2—C-MYB transcription factor network—HRAS—skin cancer	9.09e-05	0.0012	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—BRAF—skin cancer	8.62e-05	0.00114	CbGpPWpGaD
Desmopressin—PTGS2—Selenium Micronutrient Network—IL6—skin cancer	8.38e-05	0.00111	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—CSPG4—skin cancer	8.19e-05	0.00108	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—PLIN2—skin cancer	8.06e-05	0.00107	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—KRAS—skin cancer	7.89e-05	0.00104	CbGpPWpGaD
Desmopressin—PTGS2—Disease—CSPG4—skin cancer	7.76e-05	0.00103	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—TERT—skin cancer	7.54e-05	0.000996	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—TERT—skin cancer	7.49e-05	0.000989	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—TP53—skin cancer	7.24e-05	0.000957	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—HRAS—skin cancer	6.71e-05	0.000886	CbGpPWpGaD
Desmopressin—PTGS2—Spinal Cord Injury—IL6—skin cancer	6.63e-05	0.000876	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—CSPG4—skin cancer	6.5e-05	0.000859	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling by GPCR—IL6—skin cancer	6.42e-05	0.000848	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—NRAS—skin cancer	6.35e-05	0.000839	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—NRAS—skin cancer	6.31e-05	0.000833	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—BRAF—skin cancer	5.97e-05	0.000789	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—BRAF—skin cancer	5.93e-05	0.000783	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ENO2—skin cancer	5.57e-05	0.000735	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	5.54e-05	0.000732	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—KRAS—skin cancer	5.47e-05	0.000722	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—KRAS—skin cancer	5.43e-05	0.000717	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—NRAS—skin cancer	5.41e-05	0.000715	CbGpPWpGaD
Desmopressin—PTGS2—Disease—SHH—skin cancer	5.28e-05	0.000697	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ENO2—skin cancer	5.28e-05	0.000697	CbGpPWpGaD
Desmopressin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	4.93e-05	0.000651	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—KRAS—skin cancer	4.66e-05	0.000616	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—HRAS—skin cancer	4.65e-05	0.000614	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—HRAS—skin cancer	4.61e-05	0.00061	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling by GPCR—IL6—skin cancer	4.45e-05	0.000588	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ENO2—skin cancer	4.42e-05	0.000584	CbGpPWpGaD
Desmopressin—AVPR2—Signaling by GPCR—IL6—skin cancer	4.42e-05	0.000584	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	4.35e-05	0.000575	CbGpPWpGaD
Desmopressin—PTGS2—Disease—FOXO4—skin cancer	4.3e-05	0.000568	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—TP53—skin cancer	4.14e-05	0.000547	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—HRAS—skin cancer	3.96e-05	0.000523	CbGpPWpGaD
Desmopressin—AVPR1B—Signaling Pathways—IL6—skin cancer	3.79e-05	0.000501	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—NRAS—skin cancer	3.75e-05	0.000496	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—NRAS—skin cancer	3.73e-05	0.000492	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—ERCC2—skin cancer	3.23e-05	0.000427	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—KRAS—skin cancer	3.23e-05	0.000427	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—KRAS—skin cancer	3.21e-05	0.000424	CbGpPWpGaD
Desmopressin—PTGS2—Disease—ERCC2—skin cancer	3.06e-05	0.000405	CbGpPWpGaD
Desmopressin—PTGS2—Disease—TERT—skin cancer	2.87e-05	0.00038	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—TP53—skin cancer	2.87e-05	0.000379	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—TP53—skin cancer	2.85e-05	0.000377	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—HRAS—skin cancer	2.75e-05	0.000363	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—HRAS—skin cancer	2.73e-05	0.00036	CbGpPWpGaD
Desmopressin—AVPR1A—Signaling Pathways—IL6—skin cancer	2.63e-05	0.000347	CbGpPWpGaD
Desmopressin—AVPR2—Signaling Pathways—IL6—skin cancer	2.61e-05	0.000345	CbGpPWpGaD
Desmopressin—PTGS2—Metabolism—ERCC2—skin cancer	2.57e-05	0.000339	CbGpPWpGaD
Desmopressin—PTGS2—Disease—BRAF—skin cancer	2.28e-05	0.000301	CbGpPWpGaD
Desmopressin—PTGS1—Metabolism—PTGS2—skin cancer	1.94e-05	0.000256	CbGpPWpGaD
Desmopressin—PTGS2—Disease—NRAS—skin cancer	1.43e-05	0.000189	CbGpPWpGaD
Desmopressin—PTGS2—Disease—KRAS—skin cancer	1.23e-05	0.000163	CbGpPWpGaD
Desmopressin—PTGS2—Disease—HRAS—skin cancer	1.05e-05	0.000138	CbGpPWpGaD
Desmopressin—PTGS2—Disease—IL6—skin cancer	1e-05	0.000132	CbGpPWpGaD
